Prostate cancer is the most common cancer in American men, with an estimated 333,830 new cases and 36,320 deaths projected for 2026 for the disease, according to the American Cancer ...

About 60% of low‑risk prostate cancer patients are opting for active surveillance — and long‑term survival remains high.

Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer March 13, 2026 11:30 ...

Medical malpractice: Suit alleges that health care providers failed to diagnose and properly treat prostate cancer over a seven-year period, resulting in severe permanent injuries, diminished life ...

The addition of Zytiga (abiraterone) to Truqap (capivasertib) significantly prolonged radiographic progression-free survival (rPFS) in patients with PTEN-deficient metastatic hormone-sensitive ...

A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel ...

Increasing use of blood tests to detect prostate cancer is leading to overworked doctors. NTNU has now created an AI diagnostic tool that can help lighten the burden.

A new study led by researchers at The University of Texas MD Anderson Cancer Center found that prostate cancer patients with low testosterone levels may have a higher risk of cancer progressing to a ...

Newly released video captures the tense lead-up to an officer-involved shooting in central Phoenix near I-17 and 19th Avenue Friday night. A man raises his hands, commands are shouted, and his car ...

When James Choate-Deeds was diagnosed with prostate cancer, he joined a clinical trial for robotic-assisted surgery Wendy Grossman Kantor is an award-winning journalist who has contributed to PEOPLE ...

In fact, urinary-related symptoms are common — particularly as men age — and a majority of the time, they're not an indication of cancer. “The prostate naturally grows over time, which can narrow the ...